Aurobindo Pharma looks to push deeper into EU, US over next 3-4 years
"Lower generic penetration in Italy, Spain, Portugal and France offers future growth potential as share of generics improves," the company said in an investor presentation.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | France Health | Italy Health | Pharmaceuticals | Portugal Health | Spain Health